Cormorant Asset Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001583977

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q4 2025 · 35 positions · Total reported value $2.16B · Top-10 concentration 69.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 81.4% · 9 new · 37 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -24.1% · vs SPY -26.2% · Prev Value $1.95B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -13.0% · vs SPY -15.1% · Latest Value $1.40B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Cormorant Asset Management, LP disclosed 35 equity positions with a combined reported value of $2.16B. The filing implies a focused portfolio: its ten largest positions account for 69.4% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were PRAX ($280.00M), BBOT ($223.84M), ABVX ($182.05M). By sector, the heaviest allocations are Health Care 72.4%, Industrials 7.0%. Versus the prior quarter, allocation shifted toward Other (+9.5pp) and away from Industrials (-1.2pp), Health Care (-8.3pp).

Versus the prior quarter, Cormorant Asset Management, LP opened 9 new positions, trimmed 37 and fully exited 2, a turnover rate of 81.4% of positions. The portfolio's overlap with the prior quarter was 69% of names.

The largest new positions opened in Q4 2025 were QQQ ($153.58M), IWM ($123.08M), XBI ($121.93M).

Of the 2 positions fully exited versus the prior quarter, the largest were ACLX ($63.63M), CGON ($25.18M), KRRO ($22.27M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • QQQ INVESCO QQQ TR · $153.58M
  • IWM ISHARES TR · $123.08M
  • XBI SPDR SERIES TRUST · $121.93M
  • OLMA OLEMA PHARMACEUTICALS INC · $68.75M
  • ASND ASCENDIS PHARMA A/S · $21.32M
  • COGT COGENT BIOSCIENCES INC · $7.99M

Fully Exited (vs previous quarter)

  • ACLX ARCELLX INC · prev qtr: $63.63M
  • CGON CG ONCOLOGY INC · prev qtr: $25.18M
  • KRRO KORRO BIO INC · prev qtr: $22.27M
  • MTSR METSERA INC · prev qtr: $20.93M
  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $13.07M
  • BMEA BIOMEA FUSION INC · prev qtr: $7.21M
  • ELVN ENLIVEN THERAPEUTICS INC · prev qtr: $4.09M · history

Insider Transactions (Form 4)

Latest Cormorant Asset Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-29 Sell Corbus Pharmaceuticals Holdings, Inc. 425,000 $4.10 SEC filing
2026-08-10 Buy BlossomHill Therapeutics, Inc. 312,500 $16.00 SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,701,541 — SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,599,993 — SEC filing
2026-04-28 Sell BRIGHT MINDS BIOSCIENCES INC. 109,331 $89.50 SEC filing

All insider transactions →

Fund Profile

Cormorant Asset Management, LP, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 57 positions worth $1.40B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-79513 (status: Approved), registered 2014-04-15
  • Regulatory AUM (Form ADV): $3.84B as of 2026-05-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 57 positions · $1.40B reported value (Q3 2026)
  • Top 10 holdings = 56.4% of reported value
  • Largest position: PBLS (PARABILIS MEDICINES INC) at 10.7%
  • Average position size: $24.53M

Sector Tilt

  • Health Care 92.7%
  • Industrials 1.3%
  • Financials 1.1%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q3 2026: 9 new, 1 added, 37 reduced, 2 exited
  • 10 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 72.4%
Other 20.6%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 950.00K $280.00M 12.95%
12.95%
Reduce
2 17.88M $223.84M 10.35%
10.35%
Hold
3 1.35M $182.05M 8.42%
8.42%
Reduce
4 250.00K $153.58M 7.10%
7.10%
New
5 8.27M $151.00M 6.98%
6.98%
Reduce
6 500.00K $123.08M 5.69%
5.69%
New
7 1.00M $121.93M 5.64%
5.64%
New
8 3.03M $91.85M 4.25%
4.25%
Reduce
9 1.20M $91.79M 4.24%
4.24%
Reduce
10 1.06M $82.67M 3.82%
3.82%
Hold
11 3.29M $81.52M 3.77%
3.77%
Reduce
12 2.75M $68.75M 3.18%
3.18%
New
13 4.36M $57.40M 2.65%
2.65%
Add
14 275.00K $47.86M 2.21%
2.21%
Reduce
15 4.00M $36.12M 1.67%
1.67%
Add
16 3.64M $35.48M 1.64%
1.64%
Add
17 1.12M $35.32M 1.63%
1.63%
Reduce
18 1.00M $35.08M 1.62%
1.62%
Reduce
19 1.32M $33.14M 1.53%
1.53%
Reduce
20 1.08M $30.05M 1.39%
1.39%
Reduce
21 2.04M $27.00M 1.25%
1.25%
Reduce
22 100.00K $21.32M 0.99%
0.99%
New
23 250.00K $20.47M 0.95%
0.95%
Reduce
24 2.34M $19.09M 0.88%
Form 4 · 1 →
0.88%
Reduce
25 1.30M $16.51M 0.76%
0.76%
Reduce
26 533.34K $16.17M 0.75%
0.75%
Hold
27 500.00K $14.52M 0.67%
0.67%
Reduce
28 300.00K $13.96M 0.65%
0.65%
Reduce
29 75.00K $13.70M 0.63%
0.63%
Reduce
30 4.40M $9.64M 0.45%
0.45%
Reduce
31 650.00K $8.97M 0.41%
0.41%
Reduce
32 225.00K $7.99M 0.37%
0.37%
New
33 125.00K $5.77M 0.27%
0.27%
Reduce
34 400.00K $4.83M 0.22%
0.22%
Reduce
35 10.00K $112.90K 0.01%
0.01%
Hold

FAQ

What did Cormorant Asset Management, LP buy in 2025-Q4?

In its 2025-Q4 13F filing, Cormorant Asset Management, LP reported 35 equity positions worth $2.16B in aggregate; its largest disclosed positions were PRAX ($280.00M), BBOT ($223.84M), ABVX ($182.05M).

How large is Cormorant Asset Management, LP's portfolio?

Cormorant Asset Management, LP reported $2.16B of long equity holdings across 35 positions as of 2025-Q4. Top-10 holdings account for 69.4% of reported value.

What is Cormorant Asset Management, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/cormorant-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →